Central District of California Clarifies the Section 101 Analysis and Finds Another Two Patents Invalid

Nov 5, 2014

Reading Time : 2 min

Judge Pfaelzer began her discussion of Section 101 by reiterating the broad statutory categories and the narrow, judicially created exceptions. In explaining the concern about preemption that underlies the judicially created exceptions, Judge Pfaelzer explained that “[c]oncerns over preemption have called into question when, if ever, computer software is patentable.” Accordingly, she said, the “Supreme Court has heavily scrutinized algorithms and mathematical formulas under § 101.” However, she said, the “aftermath of Alice tells a [] misleading story about software eligibility” because the holding in Alice was “narrow” and only held “that an ineligible abstract idea does not become patentable simply because the claim recites a generic computer.”

Judge Pfaelzer then set out to clarify and cabin the two-step test utilized in Alice Corp. Pty. v. CLS Bank Int'l, 134 S. Ct. 2347, 2350, 189 L. Ed. 2d 296 (2014) and proffered by the Court in Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S. Ct. 1289, 1293, 182 L. Ed. 2d 321 (2012). In explaining the first step—whether the claims are directed an abstract idea, a question that many patent litigators are struggling with—Judge Pfaelzer explained, “the court must identify the purpose of the claim—in other words, determine what the claimed invention is trying to achieve—and ask whether that purpose is abstract.” Judge Pfaelzer also explained that “[c]haracterization of a claim is essential to the § 101 inquiry,” and that “[s]tep one is sort of a ‘quick look’ test, the purpose of which is to identify a risk of preemption and ineligibility.” She also clarified that “prior art plays no role” in the first step of the test. Once the court has the “purpose of the claim,” the court must determine “whether that purpose is abstract.” In that regard, Judge Pfaelzer encourages judges to make comparisons to Supreme Court precedent.

In explaining the second step, i.e., “whether there is an inventive concept that appropriately limits the claim,” Judge Pfaelzer explained that the court must “disregard well-understood, routine, conventional activity” and that a “conventional element may be one that is ubiquitous in the field, insignificant, or obvious.”  Accordingly, “conventional elements do not constitute everything in the prior art, although conventional elements and prior art may overlap.” Importantly, the court must “consider the elements as a combination,” and that “[a] combination of conventional elements may be unconventional and therefore patentable.”

Enfish, LLC v. Microsoft Corp., No. 2:12-CV-07360-MRP, 2014 WL 5661456 (C.D. Cal. Nov. 3, 2014)

Share This Insight

Categories

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.